13:46 IST
BSE
Merger & Restructuring
Orchid Pharma Merger & Restructuring
Orchid Pharma allotted 4,45,86,052 equity shares to shareholders of Dhanuka Laboratories Limited, following the approved scheme of amalgamation.
Orchid Pharma Ltd
- Share price
- ₹1,023.95
- Market cap
- ₹6,132 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 707.5×Sector 47.3×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Financial Results 4Other Announcement 3Board Meeting Date 3Merger & Restructuring 2Management Change 2Legal & Regulatory 2Acquisition 2New Order Win 1Fund Raise 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
19:32 IST
NSE
Merger & Restructuring
Orchid Pharma Merger & Restructuring
Orchid Pharma announced that the merger of Dhanuka Laboratories Limited is now effective. Dhanuka Laboratories stands dissolved following the filing of NCLT orders with the ROC.